Biotechnology and the Utilitarian Argument for Patents

Social Philosophy and Policy 13 (2):113 (1996)
  Copy   BIBTEX

Abstract

Biotechnology surpasses even computer technology in predictions of its potential for revolutionary effects on humankind. It includes agribusiness and phar-maceuticals. The U.S. government began investing heavily in biotechnology research in the 1980s, and by 1987 had spent approximately $2.7 billion to support research and development, including $150 million for agricultural biotechnology. The approximately sixty U.S. biotechnology companies invested $3.2 billion in R and D in 1991 alone, with a total of more than $10 billion spent since the industry began in the late 1970s

Other Versions

No versions found

Analytics

Added to PP
2010-08-31

Downloads
128 (#354,514)

6 months
39 (#212,600)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

Biotechnology and commodification within health care.Mark J. Hanson - 1999 - Journal of Medicine and Philosophy 24 (3):267 – 287.
Patents on drugs – the wrong prescription?Peter Dietsch - 2008 - In Axel Gosseries, Alain Marciano & Alain Strowel, Intellectual Property and Theories of Justice. Basingstoke & N.Y.: Palgrave McMillan. pp. 230-245.
Surgical patents and patients — the ethical dilemmas.Tadeusz Tołłoczko - 2005 - Science and Engineering Ethics 11 (1):61-69.
The influence of patents on science.Jonathan Trerise - 2016 - Politics, Philosophy and Economics 15 (4):424-450.

View all 9 citations / Add more citations